$1.69
3.68% today
Nasdaq, Feb 28, 04:48 pm CET
ISIN
US68375N1037
Symbol
OPK
Sector
Industry

OPKO Health, Inc. Stock price

$1.63
+0.16 10.88% 1M
-0.02 1.21% 6M
+0.16 10.88% YTD
+0.58 55.24% 1Y
-1.50 47.92% 3Y
+0.19 13.19% 5Y
-12.93 88.80% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-0.03 1.81%
ISIN
US68375N1037
Symbol
OPK
Sector
Industry

Key metrics

Market capitalization $1.11b
Enterprise Value $1.22b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.71
P/S ratio (TTM) P/S ratio 1.56
P/B ratio (TTM) P/B ratio 0.79
Revenue growth (TTM) Revenue growth -17.95%
Revenue (TTM) Revenue $711.40m
EBIT (operating result TTM) EBIT $-309.52m
Free Cash Flow (TTM) Free Cash Flow $-199.99m
Cash position $406.40m
EPS (TTM) EPS $-0.19
P/E forward negative
P/S forward 1.65
EV/Sales forward 1.81
Short interest 25.60%
Show more

Is OPKO Health, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

OPKO Health, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a OPKO Health, Inc. forecast:

6x Buy
100%

Analyst Opinions

6 Analysts have issued a OPKO Health, Inc. forecast:

Buy
100%

Financial data from OPKO Health, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
711 711
18% 18%
100%
- Direct Costs 617 617
1% 1%
87%
95 95
61% 61%
13%
- Selling and Administrative Expenses 210 210
7% 7%
30%
- Research and Development Expense 94 94
5% 5%
13%
-209 -209
393% 393%
-29%
- Depreciation and Amortization 100 100
5% 5%
14%
EBIT (Operating Income) EBIT -310 -310
109% 109%
-44%
Net Profit -134 -134
36% 36%
-19%

In millions USD.

Don't miss a Thing! We will send you all news about OPKO Health, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OPKO Health, Inc. Stock News

Neutral
Seeking Alpha
about 17 hours ago
OPKO Health, Inc. (NASDAQ:OPK ) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants Yvonne Briggs - Alliance Advisors IR Dr. Phillip Frost - Chairman and CEO Dr. Elias Zerhouni - Vice Chairman and President Adam Logal - Chief Financial Officer Gary Nabel - Chief Innovation Officer Conference Call Participants Maury Raycroft - Jefferies Jeffrey Cohen - Ladenburg Th...
Neutral
GlobeNewsWire
about 20 hours ago
MIAMI, Feb. 27, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 months ended December 31, 2024. Highlights from the fourth quarter of 2024 and recent weeks include the following: Enrollment and dosing underway by Merck in the Phase 1 Epstein-Barr virus (EBV) vaccine trial.
Neutral
GlobeNewsWire
about 2 months ago
MIAMI, Jan. 09, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 43r d Annual J.P. Morgan Healthcare Conference, being held January 13-16, 2025 at Westin St. Francis hotel in San Francisco. Management will be hosting one-on-one meetings with investors and will be presenting on Wednesday, January 15th at 3:00 p.m. Pacific time.
More OPKO Health, Inc. News

Company Profile

OPKO Health, Inc. engages in the provision of healthcare services. It operates through the following segments: Diagnostics, Pharmaceuticals, and Corporate. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Head office United States
CEO Phillip Frost
Employees 3,930
Founded 1991
Website www.opko.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today